•  
  •  
  •  
  •  

2025-10-02 22:34:20

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels launches its 6th property in Andhra Pradesh with Lemon Tree Premier, Tirupati
  • Brigade Foundation Inaugurated Freedom Fighters Memorial in Chikmagalur on Gandhi Jayanti
  • BLS UK Hotels Ltd acquires Trefeddian Hotel Aberdovey Ltd
  • Trac Precision Solutions Secures Multi-Million-Pound Project with Coolbrook to Drive Clean Tech Innovation
  • Crompton Greaves Consumer Electricals Ltd receives LoA from MPUVNL under PM KUSUM-B scheme

Keywords Selected:  Suspension

IPO News

  • Maithan Alloys Limited suspends production at Byrnihat unit

Stock Report

  • Lupin Launches Rivaroxaban for Oral Suspension in the United States
  • NATCO launches Bosentan Tablets for Oral Suspension in the United States with 180-day exclusivity
  • Lupin launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity
  • Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5% in the United States
  • Tahmar Enterprises Ltd announces temporary suspension of operations at Gadhinglaj factory
  • BSE and NSE revokes suspension of trading in equity shares of Brightcom Group Ltd
  • Vistar Amar Ltd temporarily suspends operations at Mangrol Plant
  • NILE Ltd suspends operations at Choutuppal Lead recycling plant
  • Suraj Products Ltd announces maintenance shutdown of Micro Blast Furnace
  • ZIM Laboratories Ltd announces grant of Marketing Authorization for Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in Portugal, Europe
  • La Opala announces suspension of Operations at Madhupur Opal Glass Plant
  • KIOCL Ltd to suspend operations of Pellet Plant at Mangalore from Feb 24, 2024
  • Kirloskar Ferrous Industries Ltd announces temporary suspension of operations of Mini Blast Furnace at Hiriyur plant
  • Goa Carbon Ltd temporarily suspends operations at Paradeep Unit from Jan 18, 2024
  • Lupin receives approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.2%
  • Granules India Limited Received ANDA Approval for Sildenafil for Oral Suspension
  • Eugia Pharma receives USFDA Approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule
  • RBI directs Bank of Baroda to suspend further onboarding of customers onto its 'bob World' mobile app
  • KIOCL Ltd temporarily suspends operations at Pellet Plant unit at Mangalore
  • Amarjothi Spinning Mills Ltd temporarily suspends dyeing operations at Perundurai unit
  • BLS International Services Ltd updates on suspension of Indian Visa Services in Canada
  • Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension
  • Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension
  • FCI suspends supply of surplus rice for Ethanol Products

Latest Post

  • Lemon Tree Hotels launches its 6th property in Andhra Pradesh with Lemon Tree Premier, Tirupati
  • Brigade Foundation Inaugurated Freedom Fighters Memorial in Chikmagalur on Gandhi Jayanti
  • BLS UK Hotels Ltd acquires Trefeddian Hotel Aberdovey Ltd
  • Trac Precision Solutions Secures Multi-Million-Pound Project with Coolbrook to Drive Clean Tech Innovation
  • Crompton Greaves Consumer Electricals Ltd receives LoA from MPUVNL under PM KUSUM-B scheme


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024